Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function


Autoria(s): Hodge, Jason M.; Wang, Yiming; Berk, Michael; Collier, Fiona M.; Fernandes, Tania J.; Constable, Matthew J.; Pasco, Julie A.; Dodd, Seetal; Nicholson, Geoffrey C.; Kennedy, Richard L.; Williams, Lana J.
Data(s)

01/07/2013

Identificador

http://hdl.handle.net/10536/DRO/DU:30050612

Idioma(s)

eng

Publicador

Elsevier

Relação

NHMRC 628582

NHMRC 1009367

http://dro.deakin.edu.au/eserv/DU:30050612/berk-selectiveserotonin-2013.pdf

http://dx.doi.org/10.1016/j.biopsych.2012.11.003

Direitos

2013, Elsevier

Palavras-Chave #antidepressant #apoptosis #bone #osteoblast #osteoclast #osteoporosis #selective serotonin reuptake inhibitor
Tipo

Journal Article